Securing capital is paramount for biotechnology companies striving for exponential expansion. As the field evolves, a deep understanding of financial markets becomes increasingly crucial. Venture capitalists often seek firms with a strong track record of success and compelling research. To obtain the necessary capital, biotech companies must presen